Position in GH
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$248,899
-$351,888 QoQ
Shares Held
1,659
-71.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#430
of 594 holders
Holding Since
Dec 2022
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Qsemble Capital Management, LP holds $15,729,397 across 8 Diagnostics & Research names. GH ranks #8 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
23,646 | $4,504,090 | |
| 2 | RVTY |
Revvity, Inc.
|
33,179 | $3,691,495 | |
| 3 | A |
Agilent Technologies, Inc.
|
23,610 | $3,136,116 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
|
2,460 | $1,233,345 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
5,909 | $1,141,736 | |
| 6 | WAT |
Waters Corp /De/
|
2,520 | $945,100 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
1,574 | $828,616 | |
| 8 | GH |
Guardant Health, Inc.
This page
|
1,659 | $248,899 |
All Filings in GH
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $248,899 | 1,659 | Shares | Sole | 2026-08-03 | |
| 2025-12-31 | $600,787 | 5,882 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $655,290 | 10,488 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $201,030 | 3,863 | Shares | Sole | 2025-08-11 | |
| 2023-09-30 | $341,008 | 11,505 | Shares | Sole | 2023-11-07 | |
| 2023-03-31 | $222,680 | 9,500 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $261,120 | 9,600 | Shares | Sole | 2023-02-09 | |
| No filing history on record for this holder in this stock. | ||||||